DKDaniel Kotrych

Daniel Kotrych

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Kotrych has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Combined Ozone Therapy and Negative Pressure Wound Therapy with Instillation for Charcot Neuroarthropathy-Associated Foot Wounds

    by Izabella Kuźmiuk-Glembin, Agnieszka Białomyzy, Daniel Kotrych, Michał Sadowski, Bogdan Biedunkiewicz, Leszek Tylicki, Tomasz NiewęGłowski

    Background/Objectives: Charcot neuro-osteoarthropathy (CNO) complicated by ulceration and infection represents a major limb-preservation challenge in diabetes-related foot disease. Evidence regarding the combined use of ozone therapy (OT) and negative pressure wound therapy with instillation and dwell time (NPWTi-d) remains limited. This study evaluated outcomes of a multimodal treatment protocol incorporating both modalities. Methods: This retrospective study included 30 patients with diabetes and CNO-associated foot wounds managed using a multidisciplinary protocol incorporating OT and NPWTi-d. The primary outcome was wound volume reduction, while secondary outcomes included pain, inflammatory biomarkers, microbiological findings, and safety. Results: Wound volume decreased significantly during follow-up, from a median of 8.0 cm3 at baseline to 1.5 cm3 after 3 weeks, with further reduction to 0 cm3 by week 6 (all p < 0.001). Significant improvements were observed in wound bed characteristics and exudate. Mean pain intensity (NRS) decreased from 6.9 ± 1.1 to 0.9 ± 1.1 points (p < 0.001). CRP and PCT concentrations declined significantly (both p < 0.001). Follow-up wound cultures demonstrated a lower frequency of isolation of several initially identified pathogens. No serious treatment-related adverse events occurred. Conclusions: This retrospective case series demonstrated favourable short-term changes in wound-related outcomes during a multimodal treatment strategy incorporating OT and NPWTi-d in patients with CNO-associated wounds. Given the uncontrolled study design and concurrent interventions, these findings should be considered exploratory and do not establish the independent efficacy of either modality or their combination.

  • Open Access

    Preliminary Results of Surgical Treatment for Enchondroma Using a Novel Bioactive and Osseoconductive HAP/β–Glucan Bone Substitute FlexiOss®—Case Series

    by Daniel Kotrych, Dawid Ciechanowicz, Filip Bielewicz, Andrzej Baryluk, Sebastian Podsiadło, Paweł Ziętek

    Background/Objectives: In the surgical treatment of benign bone tumors, bone substitutes are widely used. However, each of them has its advantages and disadvantages. We decided to study the novel bioactive and osseoconductive HAP/β–glucan bone substitute. Methods: We qualified eight patients with enchondroma of the lower limbs for this study, who underwent marginal resection of the lesion with the use of a bone substitute—FlexiOss®. During the 12-month follow-up, a series of X-rays and bone scintigraphy were performed. Bone remodeling was assessed using the modified Neer scale (MNS), while functional results were assessed using the MSTS scale. Results: Very good functional results were noted in all patients—MSTS = 27–30. In the MNS, Score I was recorded in six cases, and Score II was recorded in two cases. Among the complications in the two patients, a clear serous discharge from the wound was observed. Conclusions: The use of the new HAP/β–glucan composite in the treatment of enchondroma initially shows good treatment results.

  • Top Cited Papers
    Open Access

    Delay in Diagnosis and Treatment of Bone Sarcoma—Systematic Review

    by Dawid Ciechanowicz, Daniel Kotrych, Krzysztof Starszak, Piotr Prowans, Sławomir Zacha, Adam Kamiński, Adam Brodecki, Katarzyna Kotrych

    Delay in the diagnosis and treatment of rare types of cancers such as bone sarcoma still remains an important problem


  • Open Access

    Clinical Consequences of Unreconstructed Pelvic Defect Caused by Osteosarcoma with Subsequent Progressive Scoliosis in a Pediatric Patient—Case Report

    by Sławomir Zacha, Katarzyna Kotrych, Wojciech Zacha, Jowita Biernawska, Arkadiusz Ali, Dawid Ciechanowicz, Paweł Ziętek, Daniel Kotrych

    Osteosarcoma is the most common primary malignant bone tumor in children and adolescents. The standard and most effective treatment is wide resection of the tumor combined with neoadjuvant chemotherapy. Adolescent idiopathic scoliosis (AIS) is a genetically determined three-dimensional spinal deformity, which occurs in teenage patients and is mostly progressive. The basic management strategy is surgical treatment when the curve exceeds 50 degrees. However, the indications are different in oncologic patients. The aim of this study was to describe a case of adolescent scoliosis with osteosarcoma of the pelvis. The authors conducted a scoping review using PubMed and Embase to analyze the state of knowledge. The presented paper is the first report of pelvis osteosarcoma coexisting with adolescent idiopathic scoliosis. Treatment for this complex case finished with very good results, with no recurrence observed during the nine-year follow-up.


  • Open Access

    Caesarean Section for Orthopedic Indications

    by Maciej Ziętek, Paweł Ziętek, Daniel Kotrych, Małgorzata Szczuko

    Background: The increasing number of late complications described after cesarean sections is prompting a reexamination of the indications for them in pregnant women. The high percentage of pregnancies terminated by preventive cesarean section for non-obstetric reasons also largely involves orthopedic conditions. A challenge for obstetricians is pregnant patients with orthopedic conditions both before and during pregnancy. Pregnant women with a history of orthopedic surgery require special attention. The lack of consensus in this area, physicians’ fear of patients’ claims and the skewing of patients’ requests for surgical termination of pregnancy have prompted an analysis and systematization of existing knowledge in this field. Methods: References published up to 30 June 2023 in five databases Pubmed, Embase are included. Keywords have been checked for the following: pubic symphysis diastasis, lumbar disc herniation, past hip arthroplasty and fractures in the pelvic bones. In the described conditions complicating pregnancy, the mode of delivery was taken into account. Results: All included studies were screened and reviewed by at least two authors until an overall consensus of 50 articles was reached. Conclusions: Orthopedic indications for cesarean section in many cases should not be treated imperatively, since natural delivery after correct fusion of a pelvic fracture, implantation of a hip endoprosthesis or a limited dissection of the pubic symphysis is possible and is not associated with a higher risk of obstetric or orthopedic complications. Extra-obstetric indications for cesarean section should be determined individually for each pregnant woman in a multidisciplinary team, since orthopedic conditions may overlap with obstetric pathology in the pelvis.


  • Open Access

    Delay in Diagnosis and Treatment of Primary Bone Tumors during COVID-19 Pandemic in Poland

    by Daniel Kotrych, Dawid Ciechanowicz, Jakub Pawlik, Martyna Szyjkowska, Bartłomiej Kwapisz, Maciej Mądry

    Background: The COVID-19 pandemic has affected all of the medical specialties, including orthopedic oncology. Therefore, the aim of the study was to assess how it influenced the diagnostic and therapeutic processes for patients with bone neoplasms. Methods: We evaluated 87 patients treated due for bone neoplasms before (Group I, n = 36) and during the COVID-19 pandemic (Group II, n = 51). A delay in diagnosis was defined as the period between the initial clinical symptoms and the date of referral to an oncology center. The patients from Group II were asked to complete a short questionnaire regarding the COVID-19 pandemic. Results: The median general delay in diagnosis before the pandemic was 7 months, while during the pandemic, it was 10 months (p = 0.728). The biopsy delay was lower in the pre-pandemic group: median-6.5 vs. 12 days (p = 0.025). The patients from Group II were diagnosed with larger tumors compared to those in Group I: the median values were 75 vs. 56 mm (p = 0.025), respectively. After an X-ray examination, the bone neoplasms were suspected more frequently in the Group II: 63% vs. 44% cases (p = 0.024), respectively. In Group II, 20 (60.8%) cases of SARS-CoV-2 infection were reported, however, no respiratory failure cases were noticed. Conclusion: The pandemic affected the diagnostic process of primary bone tumors, resulting in delays in performing biopsies. During the pandemic, the patients reported larger diameters of their bone lesions.


  • Open Access

    Trends in Diagnosis and Surgical Treatment of Bone Metastases among Orthopedic Surgeons

    by Dawid Ciechanowicz, Daniel Kotrych, Filip Dąbrowski, Tomasz Mazurek

    Background: The proper diagnosis and treatment of bone metastases are essential for patient survival. However, several strategies for the treatment are practiced. Therefore, the aim of the study was to analyze what factors influence the choice of a method of treatment. Methods: An online survey was conducted within the Polish Society of Orthopedics and Traumatology. It consisted of 45 questions and was divided into four main parts: Participant Characteristics, Diagnosis and Qualification, Treatment, and Clinical Cases. Results: A total number of 104 responses were collected. The most frequently chosen methods were: Intramedullary nail (IMN) + Resection + Polymethyl methacrylate (PMMA) (30.47%) and IMN without tumor resection (42.13%), and in third place, modular endoprosthesis (17.25%). The less experienced group of orthopedic surgeons more often (47.5% vs. 39.5%) decided to perform IMN without tumor resection than the more experienced group (p = 0.046). Surgeons from district hospitals less frequently (13.7% vs. 23.1%) would decide to use modular endoprosthesis than surgeons from university hospitals (p = 0.000076). Orthopedists who performed ≥ 11 bone metastases surgeries per year would more often use modular endoprosthesis (34.8% vs. 13.2%) than those who performed ≤ 10 operations per year (p = 0.000114). Conclusion: Experience, place of work, and the number of metastasis surgeries performed during a year may influence the choice of treatment method in patients with bone metastases.